Home
Board Member Login
Advertising
Useful Links
Contact Us
Search
SEARCH AATOD
About Us
Organizational History
Overview of AATOD Activities
Patient Success Stories
Board of Directors
Member Center
Becoming an AATOD Member
Canon of Ethics
Membership Application
Membership Brochure
AATOD Conferences
2019 AATOD Conference – Walt Disney World
2018 AATOD Conference: New York City
2016 AATOD Conference: Baltimore
2015 AATOD Conference: Atlanta
2013 AATOD Conference: Philadelphia
2012 AATOD Conference : Las Vegas
2010 AATOD Conference : Chicago
2009 AATOD Conference: New York
2007 AATOD Conference: San Diego
2006 AATOD Conference: Atlanta
2004 AATOD Conference: Orlando
Photo Galleries
Projects/Educational Training
Preparing for EHRs and Healthcare reform for Opioid Treatment Providers
Hepatitis Education for Opioid Treatment Providers
Determining the Prevalence of Prescription Opioid Use among Admissions to Opioid Treatment Programs
Methadone Treatment in the Criminal Justice
PCSS-M Project (Methadone Mentoring)
Webinar Projects
Resources
Frequently Asked Questions
Glossary
Additional Education on Opioid Dependence
Publications & DVD’s
Calendar
Policies
Policy Statements
Whitepapers
End of Year Reports
AATOD Fact Sheets
Legislation
2013 Pre-Conference Sessions
Saturday, November 9, 2013
The Certified Medication Assisted Treatment Advocate (CMA) Training Course
Buprenorphine and Office-Based Treatment of Opioid Dependence
OTP Clinical Staff Education: Appropriate Use of Methadone in the OTP
Understanding Hepatitis in the Substance Abuse Treatment Setting
OTP Liability for Patient-Related Motor Vehicle Accidents: A Mock Trial and Focus Group Presentation
Tobacco Cessation Program for Opioid Treatment Programs
Extended-Release Naltrexone Efectiveness Findings and Clinical Experience
Sunday, November 10, 2013
Opioid Maintenance Pharmacotherapy: A Course for Clinicians
Countering Opioid Stigma: Communicating Messages to Influence Public Perception
Policy Considerations and Collaborative Partnerships: Working with Opioid Dependent Pregnant Women
From START to Finish: National and International Perspectives on Disseminating Research to Practice for the Treatment for Opioid Dependence
State Opioid Treatment Authorities’ Meeting
Opioid Treatment Program Accreditation Town Hall Meeting
Presentations by the World Federation for the Treatment of Opioid Dependence (WFTOD)
Risk Management Strategies for 2013 and Beyond
Buprenorphine and Naltrexone: The Expanding Role of Medication Assisted Treatment
Google+
LinkedIn
Facebook
Twitter
National Conference
2013 Conference Photos
2013 Conference App (New Technological Feature)
2013 – Final List of Conference Sponsors (LOGOS)
2013 Travel Discounts to the AATOD Conference
2013 AATOD Conference Volunteer Information
2013 Letter from the Conference Leadership
2013 Pre-Conference Sessions
Letter From Conference and Workshop Chairs
2013 Conference At A Glance
2013 Workshop Sessions
2013 Call for Presentations
2013 Exhibitor & Sponsorship Opportunities
2013 Poster Author Sessions
2013 Hotel Information/Reservations
2013 Awards Program
NYSWANDER/DOLE “MARIE” AWARD Recipients
2013 CME/CEH Guidelines and Fees
2013 Letter from the Conference Leadership
2013 Opioid Maintenance Pharmacotherapy: A Course for Clinicians
2013 Hot Topic Roundtables
2013 Town Hall Meeting – Addressing the Non-Medical Use of Prescription Opioids
2013 Clinic Tours
2013 Plenary Sessions
2013 Other Notable On-site Events
2013 Audio Recordings
2013 Special Needs
2013 About Philadelphia
2013 Early Registration Benefits
2013 Conference Testimonials
2013 Special Message from the Conference Leadership
FOLLOW US
Days Until
AATOD 2019 Conference
Share This
Google+
LinkedIn
Facebook
Twitter